Have a Claim?

Click here for a confidential contact or call:

1-212-350-2774

Whistleblower Case

This archive displays posts tagged as involving a whistleblower case or claim. You may also be interested in our pages:

Page 69 of 111

October 12, 2017

Posted  10/12/17
The Securities and Exchange Commission announced a whistleblower award of more than $1 million for providing the SEC with new information and substantial corroborating documentation of a securities law violation by a registered entity that impacted retail customers. It represents the 47th SEC whistleblower award and brings the total payouts under the SEC Whistleblower Program to more than $162 million. SEC

Houston-Area Hospitals Settle FCA Allegations for over $8M

Posted  10/5/17
By the C|C Whistleblower Lawyer Team Four hospitals in the Houston area have agreed to pay $8.6M to settle allegations that they received kickbacks from ambulance companies in exchange for the hospitals’ Medicare and Medicaid transport referrals. The hospitals are Bayshore Medical Center, Clear Lake Regional Medical Center, West Houston Medical Center, and East Houston Regional Medical Center. All four hospitals...

More Executives Charged in Tenet Healthcare Fraud Scheme

Posted  10/3/17
Several more executives were charged for their alleged roles in the $400 million fraud and bribery scheme involving Tenet Healthcare Corporation. The indictments follow the October 2016 guilty plea and half a billion dollar payout by Tenet and its subsidiaries for violating the False Claims Act and Anti-Kickback Statute. The allegations of the scheme originated in a whistleblower lawsuit filed under the qui tam...

DOJ Catch of the Week -- AnMed Health

Posted  09/29/17
By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to AnMed Health. On Wednesday, the South Carolina-based hospital agreed to pay more than $7 million to resolve allegations it violated the False Claims Act by submitting false Medicare claims for a variety of services, including radiation oncology services, emergency department services, and clinic services. See DOJ...

Aegerion Pharmaceuticals Will Pay More Than $40 Million to Resolve Investigations Into Its Marketing and Sales Practices

Posted  09/25/17
Aegerion Pharmaceuticals will plead guilty to charges concerning its prescription drug, Juxtapid, the Department of Justice announced on Friday.  According to the Justice Department’s press release: Aegerion introduced Juxtapid into interstate commerce that was misbranded because, among other things, Aegerion failed to comply with a Risk Evaluation and Mitigation Strategy (REMS).  The resolution also...

Texas Mortgage Companies Face $296.3M Judgment Related to Mortgage Fraud

Posted  09/21/17
By the C|C Whistleblower Lawyer Team Allied Home Mortgage, and several other Allied companies, are facing a judgment over fraudulent conduct while participating in the FHA program. In a trial last November, a jury in Houston found that the companies and their CEO violated both the FCA and FIRREA, causing over $92M in single damages to the government. Now a judgment has been ordered by the court which trebled the...

Family Medicine Centers Settles Whistleblower False Claims Act Charges

Posted  09/12/17
By the C|C Whistleblower Lawyer Team A South Carolina family medical practice chain, along with its owner and laboratory director, agreed to pay roughly $2 Million to settle charges of violating the False Claims Act and Stark Law which prohibits physician self-referrals. Specifically, Family Medicine Centers of South Carolina (FMC) agreed to pay $1.56 million, and FMC's principal owner Dr. Stephen F. Serbin and...

U.S. Government Joins Constantine Cannon Case Brought By U.K. Whistleblower against British Retailer for Customs Fraud

Posted  09/8/17
By the C|C Whistleblower Lawyer Team Constantine Cannon LLP is pleased to announce that the U.S. Government has intervened in its client's whistleblower case against Pure Collection Ltd., a Harrogate, England-based e-retailer of luxury cashmere and apparel. The Government also brought claims against Pure's current acting CEO, Samantha Harrison. The whistleblower lawsuit, among one of the first whistleblower cases...

September 7, 2017

The Hartford Dispensary will pay $627,000 through a federal-state settlement to resolve allegations that it violated the False Claims Act by falsely certifying to federal and state officials that it had a current medical director that was performing his duties in accordance with federal and state law. In 2014, the Office of the Attorney General commenced an investigation after a whistleblower complaint about the Hartford Dispensary, a private nonprofit behavioral health organization; the investigation was followed by a qui tam lawsuit alleging various violations of the state and federal False Claims Act. The state’s investigation focused on services that Hartford Dispensary provides as an opioid treatment program – primarily methadone and detoxification services.

September 5, 2017

Novo Nordisk, Inc. has agreed to $1.1 million to resolve claims that its diabetes drug Victoza was unlawfully promoted for off-label use in violation of the California Insurance Frauds Prevention Act.  The claims were brought in a whistleblower action under that act filed by former Novo Nordisk researcher Peter Dastous, who will receive a share of the settlement.  CA
1 67 68 69 70 71 111